Mirae Asset Global Etfs Holdings Ltd. Nuvectis Pharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 6,017 shares of NVCT stock, worth $36,222. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,017
Previous 7,029
14.4%
Holding current value
$36,222
Previous $52,000
30.77%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVCT
# of Institutions
54Shares Held
3.62MCall Options Held
97.7KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA699KShares$4.21 Million0.0% of portfolio
-
Ronit Capital LLP563KShares$3.39 Million5.37% of portfolio
-
Iridian Asset Management LLC406KShares$2.44 Million1.02% of portfolio
-
Baldwin Brothers LLC350KShares$2.11 Million0.15% of portfolio
-
Geode Capital Management, LLC Boston, MA326KShares$1.96 Million0.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $88.1M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...